Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Zillow Group Inc Class A — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Zillow Group Inc Class A trades at $29.49 (market cap $6.33B). The key difference: Zillow Group Inc Class A is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Zillow Group Inc Class A for 86 Days on average.
| ORKA | ZG | |
|---|---|---|
Market Cap | $5.18B | $6.33B |
Volume | 490,798 | 1,202,678 |
Sector | Health | Media |
52-Week High | $113.08 | $74.58 |
52-Week Low | $26.19 | $27.70 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $4.31B | $6.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (ZG) trades at $29.27, up 2.02% today, amid a challenging housing market. The stock is technically bearish, trading near its pivot point of $29, with key resistance at $30 and support at $28. Fundamentally, the company has returned to profitability in 2025 with a net income of $23 million, a significant improvement from prior years' losses, though its P/E ratio of 125.43 remains high. Recent news highlights competitive pressures and interest rate sensitivity.
The outlook is mixed. Analyst consensus is a 'Hold' with a $48.60 price target, implying substantial upside, but execution on its integrated transaction platform and navigating housing affordability headwinds are key. Risks include market volatility and a high valuation. The path to sustained profitability will be the primary driver for the stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
